{
  "approved_at_utc": null,
  "subreddit": "stocks",
  "selftext": "Pfizer on Tuesday said final analysis of its antiviral Covid-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients. (Source [CNBC](https://www.cnbc.com/2021/12/14/pfizer-says-covid-19-pill-near-90percent-effective-in-final-analysis-.html))\n\n* recent lab data suggests the drug retains its effectiveness against the fast-spreading omicron variant of the coronavirus.\n\n* The test was done in 2 stages, first had 1,200 participants, the second had 1,000 participants.\n\n* Pfizer also released early data from a second clinical trial showing that the treatment reduced hospitalizations by around 70% in around 600 standard-risk adults.\n\n* The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.\n\n* The U.S. government has already secured 10 million courses of the Pfizer drug for $5.29 billion.\n\nObviously a lot of us already bought Pfizer in anticipation of this news. But more noteworthy is perhaps the overall effect this may have on the economy.\n\n* Will the idea that Omicron might be controllable actually speed up rate hike?\n* Are we going to have a celebratory spending spree from consumers in 2022 Q1?\n* Does this ease lockdown fears enough for us to enjoy a sliver of the Santa rally?",
  "author_fullname": "t2_cygl",
  "saved": false,
  "mod_reason_title": null,
  "gilded": 0,
  "clicked": false,
  "title": "Pfizer says Covid-19 pill near 90% effective in final analysis. Can this save the Santa rally?",
  "link_flair_richtext": [],
  "subreddit_name_prefixed": "r/stocks",
  "hidden": false,
  "pwls": 6,
  "link_flair_css_class": "news",
  "downs": 0,
  "top_awarded_type": null,
  "hide_score": false,
  "name": "t3_rg6szk",
  "quarantine": false,
  "link_flair_text_color": "dark",
  "upvote_ratio": 0.8,
  "author_flair_background_color": null,
  "subreddit_type": "public",
  "ups": 500,
  "total_awards_received": 0,
  "media_embed": {},
  "author_flair_template_id": null,
  "is_original_content": false,
  "user_reports": [],
  "secure_media": null,
  "is_reddit_media_domain": false,
  "is_meta": false,
  "category": null,
  "secure_media_embed": {},
  "link_flair_text": "Industry News",
  "can_mod_post": false,
  "score": 500,
  "approved_by": null,
  "is_created_from_ads_ui": false,
  "author_premium": false,
  "thumbnail": "",
  "edited": 1639486466,
  "author_flair_css_class": null,
  "author_flair_richtext": [],
  "gildings": {},
  "content_categories": null,
  "is_self": true,
  "mod_note": null,
  "created": 1639486207,
  "link_flair_type": "text",
  "wls": 6,
  "removed_by_category": null,
  "banned_by": null,
  "author_flair_type": "text",
  "domain": "self.stocks",
  "allow_live_comments": false,
  "selftext_html": "&lt;!-- SC_OFF --&gt;&lt;div class=\"md\"&gt;&lt;p&gt;Pfizer on Tuesday said final analysis of its antiviral Covid-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients. (Source &lt;a href=\"https://www.cnbc.com/2021/12/14/pfizer-says-covid-19-pill-near-90percent-effective-in-final-analysis-.html\"&gt;CNBC&lt;/a&gt;)&lt;/p&gt;\n\n&lt;ul&gt;\n&lt;li&gt;&lt;p&gt;recent lab data suggests the drug retains its effectiveness against the fast-spreading omicron variant of the coronavirus.&lt;/p&gt;&lt;/li&gt;\n&lt;li&gt;&lt;p&gt;The test was done in 2 stages, first had 1,200 participants, the second had 1,000 participants.&lt;/p&gt;&lt;/li&gt;\n&lt;li&gt;&lt;p&gt;Pfizer also released early data from a second clinical trial showing that the treatment reduced hospitalizations by around 70% in around 600 standard-risk adults.&lt;/p&gt;&lt;/li&gt;\n&lt;li&gt;&lt;p&gt;The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.&lt;/p&gt;&lt;/li&gt;\n&lt;li&gt;&lt;p&gt;The U.S. government has already secured 10 million courses of the Pfizer drug for $5.29 billion.&lt;/p&gt;&lt;/li&gt;\n&lt;/ul&gt;\n\n&lt;p&gt;Obviously a lot of us already bought Pfizer in anticipation of this news. But more noteworthy is perhaps the overall effect this may have on the economy.&lt;/p&gt;\n\n&lt;ul&gt;\n&lt;li&gt;Will the idea that Omicron might be controllable actually speed up rate hike?&lt;/li&gt;\n&lt;li&gt;Are we going to have a celebratory spending spree from consumers in 2022 Q1?&lt;/li&gt;\n&lt;li&gt;Does this ease lockdown fears enough for us to enjoy a sliver of the Santa rally?&lt;/li&gt;\n&lt;/ul&gt;\n&lt;/div&gt;&lt;!-- SC_ON --&gt;",
  "likes": null,
  "suggested_sort": null,
  "banned_at_utc": null,
  "view_count": null,
  "archived": false,
  "no_follow": false,
  "is_crosspostable": false,
  "pinned": false,
  "over_18": false,
  "awarders": [],
  "media_only": false,
  "link_flair_template_id": "866eb162-65e6-11e5-a903-1252b640afe9",
  "can_gild": false,
  "spoiler": false,
  "locked": false,
  "author_flair_text": null,
  "treatment_tags": [],
  "visited": false,
  "removed_by": null,
  "num_reports": null,
  "distinguished": null,
  "subreddit_id": "t5_2qjfk",
  "author_is_blocked": false,
  "mod_reason_by": null,
  "removal_reason": null,
  "link_flair_background_color": "#80adf9",
  "id": "rg6szk",
  "is_robot_indexable": true,
  "report_reasons": null,
  "author": "r2002",
  "discussion_type": null,
  "num_comments": 74,
  "send_replies": true,
  "whitelist_status": "all_ads",
  "contest_mode": false,
  "mod_reports": [],
  "author_patreon_flair": false,
  "author_flair_text_color": null,
  "permalink": "/r/stocks/comments/rg6szk/pfizer_says_covid19_pill_near_90_effective_in/",
  "parent_whitelist_status": "all_ads",
  "stickied": false,
  "url": "https://www.reddit.com/r/stocks/comments/rg6szk/pfizer_says_covid19_pill_near_90_effective_in/",
  "subreddit_subscribers": 3380517,
  "created_utc": 1639498849,
  "num_crossposts": 0,
  "media": null,
  "is_video": false,
  "original_created_utc": 1639486207,
  "the_new_excerpt": "Pfizer on Tuesday said final analysis of its antiviral Covid-19 pill still\nshowed near 90% efficacy in preventing hospitalizations and deaths in high-risk\npatients. (Source CNBC\n[https://www.cnbc.com/2021/12/14/pfizer-says-covid-19-pill-near-90percent-effective-in-final-analysis-.html])\n\n * recent…",
  "localize": [
    {
      "locale": "ja",
      "the_new_excerpt": "ファイザーは火曜日、抗ウイルス剤Covid-19錠の最終分析がまだ終了していないと発表した。\n高リスクの入院や死亡を防ぐのに90％近い有効性があることを示した。\n患者を対象としています。(出典 CNBC\n[https://www.cnbc.com/2021/12/14/pfizer-says-covid-19-pill-near-90percent-effective-in-final-analysis-.html])\n\n *最近の...",
      "title": "ファイザー社によると、Covid-19ピルの最終分析では90%近い効果が得られたという。これでサンタラリーを救えるか？"
    },
    {
      "locale": "zh",
      "the_new_excerpt": "辉瑞公司周二表示，对其抗病毒药物Covid-19药片的最终分析仍然显示出接近90%的预防高危人群住院和死亡的功效。\n在防止高危病人住院和死亡方面的疗效接近90%。\n患者的住院和死亡。(来源：CNBC\n[https://www.cnbc.com/2021/12/14/pfizer-says-covid-19-pill-near-90percent-effective-in-final-analysis-.html])\n\n *最近...",
      "title": "辉瑞公司称Covid-19药片在最终分析中接近90%的有效性。这能拯救圣塔的反弹吗？"
    },
    {
      "locale": "zh-Hant",
      "the_new_excerpt": "輝瑞公司週二表示，對其抗病毒藥物Covid-19藥片的最終分析仍然顯示出接近90%的預防高危人羣住院和死亡的功效。\n在防止高危病人住院和死亡方面的療效接近90%。\n患者的住院和死亡。(來源：CNBC\n[https://www.cnbc.com/2021/12/14/pfizer-says-covid-19-pill-near-90percent-effective-in-final-analysis-.html])\n\n *最近...",
      "title": "輝瑞公司稱Covid-19藥片在最終分析中接近90%的有效性。這能拯救聖塔的反彈嗎？"
    }
  ],
  "source_updated_at": 1639734119996
}